Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Nalfurafine Hydrochloride
1. Nalfurafine Hydrochloride
2. 152658-17-8
3. Trk-820
4. Nopicor
5. 25cc4n0p8j
6. Refchem:831697
7. Nalfurafine Hcl
8. Remitch
9. Nalfurafine (hydrochloride)
10. Trk-820 Hydrochloride
11. (e)-n-[(4r,4as,7r,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-n-methylprop-2-enamide;hydrochloride
12. 2-propenamide,n-[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-n-methyl-, Monohydrochloride, (2e)-
13. Chembl490665
14. (e)-n-(17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl)-3-(furan-3-yl)-n-methylprop-2-enamide Monohydrochloride
15. Remitch (tn)
16. Unii-25cc4n0p8j
17. Nalfurafine Hydrochloride [usan]
18. (2e)-n-[(5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-n-methyl-2-propenamide Hydrochloride; (-)-17-(cyclopropylmethyl)-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[n-methyl-trans-3-(3-furyl)acrylamido]morphinan Hydrochloride; Remitch; Trk 820;
19. (e)-n-[17-(cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl]-3-(furan-3-yl)-n-methylprop-2-enamide Monohydrochloride
20. Ac 820
21. Nalfurafine Hydrochloride [usan:jan]
22. 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[n-methyl-trans-3-(3-furyl)acrylamido]morphinan Hydrochloride
23. Nalfurafine Hydrochloride?
24. Orb611576
25. Schembl19856501
26. Schembl29377317
27. Dtxsid70426071
28. Glxc-10447
29. Ex-a2892
30. Hy-12745a
31. Nalfurafine Hydrochloride (jan/usan)
32. Nalfurafine Hydrochloride [mi]
33. Akos030526574
34. Nalfurafine Hydrochloride [jan]
35. Nalfurafine Hydrochloride [mart.]
36. (-)-17-(cyclopropylmethyl-3,14 Beta-dihydroxy-4,5 Alpha-epoxy-6 Beta-(n-methyl-trans-3-(3-furyl)acrylamido)morphinan Hydrochloride
37. 2-propenamide, N-((5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)-3-(3-furanyl)-n-methyl-, Monohydrochloride, (2e)-
38. Ac-32785
39. Da-75979
40. Nalfurafine Hydrochloride [who-dd]
41. Ts-08357
42. D06405
43. Q27253946
44. Nalfurafine Hydrochloride(discontinued,see C4x-12682)
45. (-)-17-(cyclopropylmethyl-3,14.beta.-dihydroxy-4,5.alpha.-epoxy-6.beta.-(n-methyl-trans-3-(3-furyl)acrylamid)morphinan Hydrochloride
46. (2e)-n-[17-(cyclopropylmethyl)-3,14-dihydroxy-5alpha-4,5-epoxymorphinan-6beta-yl]-3-(furan-3-yl)-n-methylprop-2-enamide--hydrogen Chloride (1/1)
47. 2-propenamide, N-((5.alpha.,6.beta.)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)-3-(3-furanyl)-n-methyl-, Monohydrochloride, (2e)-
| Molecular Weight | 513.0 g/mol |
|---|---|
| Molecular Formula | C28H33ClN2O5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 86.4 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 893 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Severe uraemic pruritus
ABOUT THIS PAGE
32
PharmaCompass offers a list of Nalfurafine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nalfurafine Hydrochloride manufacturer or Nalfurafine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nalfurafine Hydrochloride manufacturer or Nalfurafine Hydrochloride supplier.
A Nalfurafine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nalfurafine Hydrochloride, including repackagers and relabelers. The FDA regulates Nalfurafine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nalfurafine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nalfurafine Hydrochloride supplier is an individual or a company that provides Nalfurafine Hydrochloride active pharmaceutical ingredient (API) or Nalfurafine Hydrochloride finished formulations upon request. The Nalfurafine Hydrochloride suppliers may include Nalfurafine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Nalfurafine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nalfurafine Hydrochloride Drug Master File in Korea (Nalfurafine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nalfurafine Hydrochloride. The MFDS reviews the Nalfurafine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Nalfurafine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nalfurafine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nalfurafine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nalfurafine Hydrochloride suppliers with KDMF on PharmaCompass.
Nalfurafine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nalfurafine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nalfurafine Hydrochloride GMP manufacturer or Nalfurafine Hydrochloride GMP API supplier for your needs.
A Nalfurafine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Nalfurafine Hydrochloride's compliance with Nalfurafine Hydrochloride specifications and serves as a tool for batch-level quality control.
Nalfurafine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Nalfurafine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nalfurafine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Nalfurafine Hydrochloride EP), Nalfurafine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nalfurafine Hydrochloride USP).
